Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has shared an update.
Shandong Boan Biotechnology has entered into a finance lease agreement with Industrial Bank Financial Leasing under which the bank will purchase certain machinery and equipment from the company for RMB41.1 million and lease them back to Shandong Boan for 36 months, with payments made in 12 quarterly instalments at a floating rate of 40 basis points over the LPR. The transaction, structured as a sale-and-leaseback with a token repurchase price of RMB1 at the end of the term and backed by a third-party guarantee, is intended to replenish the company’s working capital, optimise its mix of long- and short-term financing, and support ongoing operations and strategic initiatives, which the board views as fair, reasonable and in the interests of shareholders.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company based in the People’s Republic of China and listed in Hong Kong, engaged in developing and producing biotechnology-driven pharmaceutical products and related therapies for domestic and international markets.
Average Trading Volume: 5,582,735
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.84B
Learn more about 6955 stock on TipRanks’ Stock Analysis page.